0001144204-14-043289.txt : 20140716 0001144204-14-043289.hdr.sgml : 20140716 20140716101830 ACCESSION NUMBER: 0001144204-14-043289 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20140716 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140716 DATE AS OF CHANGE: 20140716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HARRIS & HARRIS GROUP INC /NY/ CENTRAL INDEX KEY: 0000893739 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 133119827 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 814-00176 FILM NUMBER: 14977231 BUSINESS ADDRESS: STREET 1: 1450 BROADWAY STREET 2: FLOOR 24 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-582-0900 MAIL ADDRESS: STREET 1: 1450 BROADWAY STREET 2: FLOOR 24 CITY: NEW YORK STATE: NY ZIP: 10018 8-K 1 v383996_8k.htm FORM 8-K

 

 
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

______

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

July 16, 2014 (July 16, 2014)

______

 

HARRIS & HARRIS GROUP, INC.

 

(Exact name of registrant as specified in its charter)

         
New York
(State or other jurisdiction of
incorporation)
  0-11576
(Commission File
Number)
  13-3119827
(IRS Employer
Identification No.)

______

 

1450 Broadway
New York, New York 10018

 

 

(Address of principal executive offices and zip code)

 

(212) 582-0900

 

 

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 8.01.     Other Events.

 

On July 16, 2014, Harris & Harris Group, Inc. (the "Company") announced its investment in UberSeq, Inc. The Company invested $500,000 in UberSeq's Series Seed Financing in June of 2014. UberSeq is a translational genomics company originated from Stanford University.  The Company’s press release is attached hereto as Exhibit 99.1.

 

Item 9.01.     Financial Statements and Exhibits.

 

(a)Not applicable.

 

(b)Not applicable.

 

(c)Not applicable.

 

(d)Exhibits.

 

  Exhibit No. Description
     
  99.1 Press Release dated July 16, 2014

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 16, 2014 HARRIS & HARRIS GROUP, INC.
     
     
     
     
  By: /s/ Douglas W. Jamison         
    Douglas W. Jamison
    Chief Executive Officer

 

 
 

 

EXHIBIT INDEX

 

  Exhibit No. Description
     
  99.1 Press Release dated July 16, 2014

 

 

 

EX-99.1 2 v383996_ex99-1.htm EXHIBIT 99.1

 

DBW's Laptop Hard Drive:Users:daniel:Library:Caches:TemporaryItems:Outlook Temp:H&H Final Logo:harris_harris_final_logo.eps

 

 

Harris & Harris Group Invests in UberSeq, Inc.

 

NEW YORK, NY – July 16, 2014 – Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, announced today its investment in UberSeq, Inc. Harris & Harris Group invested $500,000 in UberSeq's Series Seed Financing in June of 2014. UberSeq is a translational genomics company that originated from Stanford University.

 

"Personalized genomics are now coming through a rapid evolution, akin to that of the semiconductor industry 30 years ago. We believe that this ongoing shift should allow well positioned players like UberSeq to benefit disproportionally from the industry's transformation," said Alexei Andreev, a Managing Director of Harris & Harris Group. "UberSeq is another example of Harris & Harris Group being actively involved in the launching and building of exciting BIOLOGY+ companies addressing real market needs," said Douglas Jamison, CEO of Harris & Harris Group. "Look for us to continue to make these types of investments."

 

 

About Harris & Harris Group

Harris & Harris Group is a publicly traded venture capital firm that is also a business development company. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com, on Facebook at www.facebook.com/harrisharrisvc and by following on Twitter @harrisandharrisgroup.

 

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.

 

 

Press contact

 

Jessica Attanasio

Associate Vice President

Gregory FCA

Jessica@GregoryFCA.com

610-228-2112

 

 

 

GRAPHIC 3 image_001.gif GRAPHIC begin 644 image_001.gif M1TE&.#EA'P$Z`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y M!`$`````+``````>`3H`@0```$='1Z.CH]J-(`+_!&:7@]8)HPDI4&"KW+S[ M#X;B2);FB:;JPAPM\[:A1=%39J_ZSO?^#^S!7`B8\?&QT9:U3/`)C4JG5!?+ MT9")G-R+LPH.B\?A!S)U\:3)[+;['1K*9<,9KMM=*25=,>41Z@7 MD:/VU6'8N/&8J#A9L00$25D)L>CXB,A$R'B)%9AU>N;IM7JSV3H*"B*9:2GI MR3'K0UL;"VJH^HE;F>LGT6F\6^MZPTF*W'QL&=F9#%''"#M:C:'G3*DY'+YF M`TA4NE7X&JV9+>P]C1P>+PR/V:/8#UW!9?Y9A<0V#R([E1LCIF*9DAXWDO)@ MOK)YLIBL:B5SE,R)$.>NBRYW)EP)5.A#I"V91NC8X&=0/#,1'6V:]!O.K%RY MONLP4)#&F#%[.L2X=>@NJ`.^4C0X7 MPRK7>F>>4,.OSB3&,O4XGLMJ:GTL>1) MG/]&']U[ZV57V&`"[F?44SN4QR!YB1B8'H30!?@96!_!]YZ$QVT('VOE;31$ M#C(XH447-YFH7$;Y8,@A@BFVJ!I#*BY(W',OKJ:6>EYE%&(&1ES2XW95P661 M@TX=2912:)DG50E&L@AC<4J6YHV(+9`SHH]7%G*(8X=X5UU7T>4XI9*D\?!D MF(3I==B#9U7V0!I(R*F!=&F,4R>8C#5Y#)LL1J/77FC42"&3@;F97(M_K:%% MG!>4F.<7=P:'@4Z67HKI"?)IB8!]0GK:Y6F9CDIJ'YM2$.20GM;W6*FNOEJ, M&:!E"9JDM=X):ZZZOB'K!-;D^5*EOD:Z:['&4K'I.5C_=KJJER\>"VVT*9S* MV;+?J?I+D])NRZT$'D7U*+BHTLJJ2=IVBVZZPJ[`H+KNOFO.JMC.2Z^\)`B` M+[X>Y)OO"?V"H&\'_T;`;\#PZI0JD0.FH[`(!1?,PXRS"@/+#'/,.R=P ML\PU\YSQT$`;;<#/.8MAK;/`L?KEQ4A3C+32-$O=,]8J3VWUTE0`"7)LC7TB M5=]==MKMPQWX!>CH/3/9O^] M]]9<+XZWX%#(.W.N>*GNPZ\VK@?C;'9I2===>.]W_XR\%_7 MC86+*TZ^#._+$X\]X!3GSCWKSL>=SH_G@GH)[]`#*-3B4S M8`6'134(MFYM_UO@^7;G0`!*$!._N[6\5TM\((CK`*(-CX,R9-[Q=+@^$P>U9& @G'6N*1EJD6X+RR'Y[+7%,)K@-RAZ&A)C)\8T=J```#L_ ` end